About TransMedics
TransMedics is a company based in Andover (United States) founded in 1998. TransMedics has raised $265.55 million across 16 funding rounds from investors including Canadian Imperial Bank of Commerce, United Therapeutics and Kleiner Perkins. The company has 728 employees as of December 31, 2024. TransMedics has completed 2 acquisitions, including Summit Aviation and TransMedics Aviation. TransMedics offers products and services including OCS Lung, OCS Heart, OCS Liver, and OCS DCD Heart. TransMedics operates in a competitive market with competitors including OrganOx, Paragonix Technologies, Bridge to Life, Vascular Perfusion and ADVITOS, among others.
- Headquarter Andover, United States
- Employees 728 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Transmedics Group, Inc.
-
Annual Revenue
$441.54 M (USD)82.74as on Dec 31, 2024
-
Net Profit
$35.46 M (USD)0as on Dec 31, 2024
-
EBITDA
$57.25 M (USD)553.44as on Dec 31, 2024
-
Total Equity Funding
$265.55 M (USD)
in 16 rounds
-
Latest Funding Round
$60 M (USD), Debt – Conventional
Sep 15, 2022
-
Investors
Canadian Imperial Bank of Commerce
& 15 more
-
Employee Count
728
as on Dec 31, 2024
-
Investments & Acquisitions
Summit Aviation
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of TransMedics
TransMedics is a publicly listed company on the NASDAQ with ticker symbol TMDX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of TransMedics
TransMedics offers a comprehensive portfolio of products and services, including OCS Lung, OCS Heart, OCS Liver, and OCS DCD Heart.
Technology for preserving lungs during transplantation procedures
Device for maintaining heart viability in transplants
System to preserve livers for successful transplantation
Approved technology for hearts from donation after circulatory death
People of TransMedics
Unlock access to complete
Unlock access to complete
Funding Insights of TransMedics
TransMedics has successfully raised a total of $265.55M across 16 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $60 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TransMedics
TransMedics has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce, United Therapeutics and Kleiner Perkins.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are managed by Abrams Capital across the United States.
|
Locked | Locked | Locked | |
|
Life sciences-focused venture capital firm
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early-stage tech startups
|
Locked | Locked | Locked |
Investor details for TransMedics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TransMedics
TransMedics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Summit Aviation and TransMedics Aviation.
Investment portfolio details for TransMedics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Aviation degrees and flight training services are provided.
|
Locked | Locked | 2000 | Locked | |
|
Full service aviation centre offering aircraft maintenance, repair, modifications, flight school, private jet charter, and aircraft management solutions
|
Locked | Locked | 1960 | Locked |
Complete acquisition details for TransMedics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - TransMedics
Detailed financials for TransMedics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Transmedics Comparisons
Peer comparison for TransMedics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TransMedics
TransMedics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OrganOx, Paragonix Technologies, Bridge to Life, Vascular Perfusion and ADVITOS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Warm storage and transport systems for harvested organs are provided.
|
|
| Locked | Locked | Locked |
Organ preservation and transport systems are developed for transplants.
|
|
| Locked | Locked | Locked |
Cold storage solutions for organ transplant preservation are provided.
|
|
| Locked | Locked | Locked |
Developer of a device for organ preservation
|
|
| Locked | Locked | Locked |
Multi-organ support systems for liver, lung, and kidney are provided.
|
Detailed competitors of TransMedics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Transmedics
Complete news archive for TransMedics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TransMedics
TransMedics was founded in 1998 and raised its 1st funding round 2 years after it was founded.
TransMedics is headquartered in Andover, United States. It is registered at Andover, Massachusetts, United States.
TransMedics is a funded company, having raised a total of $265.55M across 16 funding rounds to date.
As of Dec 31, 2024, the latest employee count at TransMedics is 728.
Annual revenue of TransMedics is $441.54M as on Dec 31, 2024.
TransMedics was founded in 1998 in Andover, United States, within the medical device sector focused on organ transplantation. The Organ Care System (OCS) has been created as a portable technology that keeps organs functioning outside the body, featuring a wireless monitor, organ-specific perfusion module, and solution set. Versions for heart, lungs, and liver are available, with commercial distribution occurring in Europe and Australia.
TransMedics's top competitors include OrganOx, ADVITOS and Paragonix Technologies.
TransMedics offers OCS Lung, OCS Heart, OCS Liver, and OCS DCD Heart.
Yes, TransMedics is publicly traded on NASDAQ under the ticker symbol TMDX.
TransMedics has made 2 acquisitions, including Summit Aviation, and TransMedics Aviation.
TransMedics has 16 investors. Key investors include Canadian Imperial Bank of Commerce, United Therapeutics, Kleiner Perkins, Hercules Capital, and Flagship Pioneering.
The ticker symbol of TransMedics is TMDX on NASDAQ.